Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Non-Hodgkin 2Lymphoproliferative Disorders 1Lymphomatoid Granulomatosis 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Epstein-Barr Virus Infections 1

Interventions

Rituximab 3Vincristine 2Prednisone 2Matrix-M 2Etoposide 2Doxorubicin 2Cyclophosphamide 2threonic acid 1pomalidomide 1Zidovudine 1Tomography, X-Ray Computed 1Nivolumab 1Methotrexate 1Magnesium Sulfate 1Leucovorin 1Interferons 1Echocardiography 1EPOCH protocol 1Caves 1Acyclovir 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Epstein-Barr Virus Infections × EPOCH protocol × Clear all
NCT00001379 2025-06-19

Treatment and Natural History Study of Lymphomatoid Granulomatosis

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
94 enrolled 20 charts
Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Lymphoproliferative Disorders, Epstein-Barr Virus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡